Probiotics for gut health and immunity: which strain to choose and when to use

Probiotics are one of those supplement segments where marketing definitely outpaces science – in stores and pharmacies, you can find products labeled as "the strongest probiotics" without any indication of what specific strain is inside. The problem is that the effectiveness of probiotics is strictly strain-specific: L. rhamnosus GG helps with diarrhea, but not with IBS. B. infantis provides relief for IBS, but not for traveler's diarrhea. This article explains what science says about specific strains, how to read probiotic labels, and how to match your choice to your health issue.

KEY INFORMATION
• Hill et al. (Nature Reviews Gastroenterology and Hepatology, 2014) defined probiotics and established that scientific evidence is strain-specific – one cannot generalize from one strain to another.
• L. rhamnosus GG ma najsilniejsze dowody przy biegunkach i AAD (antibiotic-associated diarrhea).
• S. boulardii is a yeast (not a bacterium) – it survives in the presence of antibiotics and is the gold standard for AAD.
• Recommended CFU: 10–20 billion CFU for basic support; the strain is more important than the number of CFU.

What are probiotics and why does the strain matter?

Probiotics are defined as Hill et al. (Nature Reviews Gastroenterology and Hepatology, 2014) „live microorganisms that, when administered in adequate amounts, confer a health benefit on the host”. The key words are: „live” and „adequate amounts”. Strain specificity is also crucial: the properties of one strain of L. rhamnosus may not be the same as another strain of L. rhamnosus. Scientific documentation pertains to specific strains identified by their full name (genus + species + strain designation), e.g., Lactobacillus rhamnosus GG (manufacturer: Valio, designation: ATCC 53103).

The gut-associated lymphoid tissue (GALT) contains about 70% of all immune cells in the body. The gut microbiota has been „training” this system since birth, modulating tolerance and immune reactivity. Dysbiosis (disruption of the microbiota composition) correlates with inflammatory conditions, autoimmune diseases, allergies, obesity, and depression. Probiotics – when the strain is properly selected – can support the restoration and maintenance of a healthy microbiota.

Our observations: The most common mistake when buying a probiotic is choosing based on the number of billions of CFU and price – without checking which specific strain (or strains) is in the product. A product with 50 billion CFU of an unknown strain of „Lactobacillus rhamnosus” may be less effective than a product with 10 billion CFU of a documented strain of L. rhamnosus GG. Look for products with full strain names on the label.

L. rhamnosus GG – the gold standard for diarrhea

Lactobacillus rhamnosus GG (LGG) is one of the most well-researched probiotic strains in the world, with hundreds of clinical studies. Its main documented applications are: infectious diarrhea (especially rotavirus in children), traveler's diarrhea, and antibiotic-associated diarrhea (AAD).

Meta-analysis Allen et al. (Cochrane Database, 2010) included 63 clinical studies with a total of 8014 participants and showed that LGG shortens the duration of infectious diarrhea in children by about 1 day and reduces the risk of diarrhea lasting more than 3 days by 59%. In AAD: LGG reduces the risk by 60–70% compared to placebo. Dosage: 10–20 billion CFU of LGG daily, preferably in the form of a capsule with the lyophilized strain.

Saccharomyces boulardii – essential during antibiotic therapy

S. boulardii is a yeast (Saccharomyces cerevisiae boulardii), not a bacterium – which has a key practical advantage: antibiotics do not kill it. This makes S. boulardii ideal for simultaneous use with antibiotics for the prevention of AAD. McFarland (Trials, 2010) in a meta-analysis of 16 RCTs, it was shown that S. boulardii reduced AAD by 51.9% in hospitalized patients receiving antibiotics.

S. boulardii is also effective for diarrhea associated with Clostridioides difficile (C. diff) – one of the most difficult intestinal pathogens to treat, often causing relapses after antibiotic therapy. McFarland et al. (JAMA, 1994) it was shown that S. boulardii + standard C. diff therapy reduced relapses by 50% vs placebo. Dosage: 500–1000 mg of S. boulardii daily during and after antibiotic therapy.

B. infantis and L. plantarum – for IBS and immunity

Bifidobacterium infantis 35624 is a strain with documented efficacy for irritable bowel syndrome (IBS). O’Mahony et al. (Gastroenterology, 2005) in a randomized, double-blind study, it was shown that B. infantis 35624 over 8 weeks in patients with IBS reduced abdominal pain, bloating, and the feeling of incomplete bowel emptying compared to placebo. This strain also has immunomodulatory properties – it lowered the IL-10/IL-12 ratio, indicating a restoration of immune tolerance. Dosage: 10 billion CFU daily for a minimum of 8 weeks (IBS effects take time).

Lactobacillus plantarum 299v (Lp299v) has strong evidence for IBS, but also interesting data regarding immunity. A randomized study using Lp299v for 12 weeks in healthy adults showed a 33% reduction in the number of cold episodes during the fall season. Lp299v colonizes the small intestine more strongly than other Lactobacillus, which may explain the more pronounced immunological effect. Lp299v is also well-studied for improving iron absorption – Bering et al. (American Journal of Clinical Nutrition, 2006) it was shown to have 50% higher iron absorption from meals when fermented oatmeal with Lp299v was used.

It is worth noting several strains of Bifidobacterium not discussed above: B. lactis BB-12 is the most well-researched strain from the Bifidobacterium family with over 400 publications – reducing AAD, supporting immunity in infants, shortening the duration of rotavirus diarrhea. B. longum BB536 (Morinaga) has documented properties for allergic rhinitis – it reduced symptoms in patients with seasonal allergies in a Japanese RCT. For individuals over 50, where the pool of Bifidobacterium naturally decreases, supplementation with Bifidobacterium is particularly justified.

Probiotics and immunity – mechanisms and evidence

The relationship between the microbiome and immunity is crucial in modern immunology. The intestines are the largest immune organ – GALT (gut-associated lymphoid tissue) accounts for about 70% of all immune cells in the body. The microbiota modulates the balance between Th1/Th2/Treg responses and the production of immunoglobulin class IgA (the first line of defense on mucosal surfaces).

Probiotics influence immunity through several mechanisms: stimulation of IgA production by GALT plasma cells, modulation of cytokines (IL-10 – anti-inflammatory, IL-12 – pro-inflammatory, interference with NF-κB), and strengthening the intestinal barrier by increasing the production of mucin and tight-junction proteins (occludin, claudin). Borchers et al. (Clinical Reviews in Allergy and Immunology, 2009) they described the detailed mechanisms of immunomodulation by Lactobacillus and Bifidobacterium.

In the prevention of upper respiratory infections: meta-analytical studies indicate a 12–17% reduction in the number of cold episodes with regular probiotic use during the autumn-winter season. The effects are more pronounced in children, the elderly, and elite athletes (where intense effort suppresses immunity). Hao et al. (Cochrane Database, 2015) in a review of 13 RCTs, they showed that probiotics shorten the duration of a cold by 1–2 days.

The gut-brain axis and psychobiotics – a new area of research

One of the most fascinating research directions is the gut-brain axis: a bidirectional communication between the gut microbiota and the central nervous system via the vagus nerve, the enteric nervous system (ENS), cytokines, and microbial metabolites such as short-chain fatty acids (SCFA: butyrate, propionate, acetate). Over 90% of serotonin produced in the body comes from the gut – from enterochromaffin cells stimulated by the microbiota.

Psychobiotics is a term proposed by Dinan et al. (Biological Psychiatry, 2013) to describe probiotics that positively affect mental health through the gut-brain axis. The best-studied in this context are: L. helveticus R0052 + B. longum R0175 – the combination used in the RCT by Messaoudi et al. (British Journal of Nutrition, 2011), where 30 days of supplementation reduced Hopkins Symptom Checklist scores (a measure of psychological stress) by 24% vs placebo. Participants also reported reduced anxiety and improved sleep quality.

Messaoudi et al. (British Journal of Nutrition, 2011) in a study of 55 healthy adults, they showed that the combination of L. helveticus R0052 and B. longum R0175 for 30 days significantly reduced morning cortisol in urine (a measure of HPA axis activation under stress) and improved anxiety and depression subscales compared to placebo. The effects were more pronounced in individuals with initially higher stress levels. This study opened wide interest in psychobiotics, although the field still requires large, multicenter RCTs to confirm efficacy.

The psychobiotic mechanism involves several pathways: GABA production by Lactobacillus (GABA reduces nervous system activity and anxiety), stimulation of serotonin secretion by enterochromaffin cells, modulation of the vagus nerve (the sensory nerve transmitting signals from the gut to the brain), and reduction of systemic inflammation, which is linked to depression. It is also worth noting that gut dysbiosis correlates with the severity of IBS symptoms in individuals with concurrent depression and anxiety – here probiotics may act doubly: on the gut and mood.

When and how to take probiotics?

The survival of probiotics through the acidic environment of the stomach (pH 1.5–3.5) is crucial. Most strains survive better when the capsule is taken with a meal or just before it – food buffers stomach acidity and shortens the exposure time of probiotics to low pH. Enteric-coated capsules (delayed release) protect probiotics from stomach acid regardless of meals.

During antibiotic therapy: take the probiotic 2–3 hours after the antibiotic (not together – the antibiotic kills the probiotics). S. boulardii as a yeast is an exception – antibiotics do not eliminate it, so it can be taken simultaneously with the antibiotic. After completing antibiotic therapy: continue for 2–4 weeks with a probiotic containing L. rhamnosus GG to restore the microbiota.

Storage: most lyophilized probiotics are stable at room temperature for the time indicated on the packaging. Liquid or fresh forms (yogurts, kefirs) require refrigeration. Check the expiration – CFU significantly decreases after the expiration date. A good manufacturer declares CFU "at expiry", not "at manufacture".

Duration of treatment: for therapeutic indications (IBS, AAD), a minimum of 8–12 weeks of continuous supplementation is required to assess the effect. Probiotics do not work like medications – colonization and modulation of the microbiota are processes that take weeks, not hours. In cases of acute infections (rotavirus diarrhea in children), the effect of LGG is visible within 1–2 days, but the mechanism is different (direct competition with the pathogen, not long-term modulation of the microbiota). Do not stop treatment after 2 weeks just because you do not see effects – strains like B. infantis need a full 8 weeks.

More about natural methods of supporting gut health is discussed in the article Naturalne suplementy na zdrowie. You can read about how magnesium affects stress and the gut-brain axis in the article Magnez na stres i sen.

How to read probiotic labels – a practical guide

The probiotic market is one of the more chaotic in supplementation – manufacturers use various marketing tricks that complicate the assessment of product quality. Here’s what to check before purchasing:

• Full strain name: the label should provide the genus + species + strain designation, e.g., "Lactobacillus rhamnosus GG" or "Bifidobacterium lactis BB-12". Just "Lactobacillus rhamnosus" is insufficient – it is unclear which strain is being referred to or whether it has clinical studies.
• CFU „at expiry”: the manufacturer should guarantee CFU at the end of the expiration period, not at the time of production – the bacterial count decreases over time. A product declaring "50 billion CFU at manufacture" may have 5 billion CFU at purchase.
• Storage conditions: check whether it requires refrigeration or is stable at room temperature. Lyophilized strains in capsules with moisture absorbers are usually stable at 20–25°C for 12–24 months.
• Protective coating: DR (delayed release) capsules or MAKTrek protect probiotics from stomach acid. Without a coating, probiotics taken on an empty stomach may lose 90% of their viability.
• Prebiotic in the composition: synbiotics (probiotic + prebiotic, e.g., FOS, inulin) can improve the survival of bacteria in the gut. Check if the prebiotic dose is sufficient (min. 1–3 g of FOS or inulin).

Our observations: Comparing products available on the Polish market, we notice that many popular pharmacy probiotics only state "Lactobacillus acidophilus" or "Bifidobacterium bifidum" without strain designation. This makes it impossible to assess what clinical studies support the product. Products from reputable lines (Culturelle: LGG, Align: B. infantis 35624, Jarrow Formulas: L. reuteri DSM 17938) are transparent about the strain and have their own clinical studies.

Frequently Asked Questions

Which probiotic strain is the best?

It depends on the purpose. L. rhamnosus GG – diarrhea, AAD. S. boulardii – antibiotics, C. diff. B. infantis 35624 – IBS and bloating. L. plantarum 299v – immunity, IBS, iron absorption. There is no strain "for everything" – Hill et al. (2014) emphasized strain-specificity of the evidence.

How many CFUs should a good probiotic have?

10–20 billion CFU is the basis for most indications. Higher doses (50+ billion) are not automatically better – the specific, documented strain is more important. Check if the label provides the full strain designation (genus + species + strain number), not just the genus.

When to take probiotics – before or after antibiotics?

During therapy: 2–3 hours after taking antibiotics (exception: S. boulardii – survives antibiotics, can be taken simultaneously). After therapy: continue for 2–4 weeks. McFarland (2010) confirmed in a meta-analysis that S. boulardii or LGG reduced AAD by over 50%.

Are prebiotics more important than probiotics?

Both are important. Prebiotics (fermentable fiber from vegetables, fruits, legumes, seeds) feed gut bacteria continuously – this is the foundation. Probiotics are a supplement, especially after microbiota disruption (antibiotics, infection, stress). "Synbiotics" (a combination of pre- and probiotics) may provide a better synergistic effect than either alone.

Do probiotics help with immunity?

Hao et al. (Cochrane, 2015) demonstrated in 13 RCTs that probiotics shortened the duration of colds by 1–2 days. Regular use of L. plantarum or L. acidophilus during the fall-winter season may reduce the number of cold episodes. The effects are stronger in children and seniors than in healthy middle-aged adults.

Can probiotics improve mood and reduce stress?

Research on psychobiotics is promising, but still early. The most studied combination is L. helveticus R0052 + B. longum R0175 – Messaoudi et al. (British Journal of Nutrition, 2011) showed a reduction in morning cortisol and improvement in anxiety indicators after 30 days. However, the effects are moderate and more pronounced in individuals with initially high stress than in healthy individuals.

What fermented products can replace probiotics?

Fermented dairy products (kefir, natural yogurt with live cultures), kimchi, sauerkraut, tempeh, and kombucha contain live microorganisms. Pasteurized kefir (heated after fermentation) does not contain live bacteria – check the label. Milk kefir with live cultures provides L. kefir, L. acidophilus, and Bifidobacterium. For therapeutic effects (IBS, AAD), however, fermented products are too unpredictable regarding strain and CFU – a standardized supplement is needed here.

This article is for informational and educational purposes and does not replace consultation with a doctor. If you are pregnant, breastfeeding, taking medications, or have chronic conditions, consult the use of supplements or herbs with a specialist.

Author: Michał Waluk · Published: 2026-05-04 · Updated: 2026-05-04